These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22565408)

  • 1. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant.
    Favaloro EJ; Bonar R; Marsden K
    Semin Thromb Hemost; 2012 Jun; 38(4):404-11. PubMed ID: 22565408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies.
    Favaloro EJ; Wheatland L; Jovanovich S; Roberts-Thomson P; Wong RC
    Semin Thromb Hemost; 2012 Jun; 38(4):390-403. PubMed ID: 22570184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current international initiatives in antiphospholipid antibody testing.
    Willis R; Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2012 Jun; 38(4):360-74. PubMed ID: 22576664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
    Favaloro EJ; Wong RC
    Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
    Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
    Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA; Krilis SA
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants.
    Favaloro EJ
    Int J Lab Hematol; 2013 Jun; 35(3):269-74. PubMed ID: 23590654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?
    Tonello M; Bison E; Cattini MG; Pontara E; Iaccarino L; Denas G; Cheng C; Pengo V
    Clin Chem Lab Med; 2021 Nov; 59(12):1950-1953. PubMed ID: 34390635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.